These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29372417)

  • 21. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.
    Yanagida R; Czer LS; Mirocha J; Rafiei M; Esmailian F; Moriguchi J; Kobashigawa JA; Trento A
    Transplant Proc; 2014 Dec; 46(10):3575-9. PubMed ID: 25498092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Obesity on Left Ventricular Assist Device Outcomes.
    Zhigalov K; Sá MPBO; Arjomandi Rad A; Vardanyan R; Goerdt L; Chrosch T; Zubarevich A; Wendt D; Pizanis N; Koch A; Kamler M; Berger R; Schmack B; Ruhparwar A; Popov AF; Weymann A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33113962
    [No Abstract]   [Full Text] [Related]  

  • 26. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD.
    Tran HA; Pollema TL; Silva Enciso J; Greenberg BH; Barnard DD; Adler ED; Pretorius VG
    ASAIO J; 2018; 64(3):323-327. PubMed ID: 28841580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support.
    Kawabori M; Conyer RT; Kurihara C; Sugiura T; Civitello AB; Frazier OH; Morgan JA
    Ann Thorac Surg; 2019 Apr; 107(4):1132-1138. PubMed ID: 30465757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimally Invasive Implantation of Continuous Flow Left Ventricular Assist Devices: The Evolution of Surgical Techniques in a Single-Center Experience.
    Carrozzini M; Bejko J; Guariento A; Rubino M; Bianco R; Tarzia V; Gregori D; Bottio T; Gerosa G
    Artif Organs; 2019 Mar; 43(3):E41-E52. PubMed ID: 30062796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion.
    Yoshioka D; Takayama H; Garan RA; Topkara VK; Han J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):828-834. PubMed ID: 28329284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices.
    Clerkin KJ; Naka Y; Mancini DM; Colombo PC; Topkara VK
    JACC Heart Fail; 2016 Oct; 4(10):761-768. PubMed ID: 27614942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation.
    Critsinelis AC; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    Am J Cardiol; 2017 Dec; 120(11):1998-2002. PubMed ID: 28958451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection.
    Olmsted RZ; Critsinelis A; Kurihara C; Kawabori M; Sugiura T; Civitello AB; Morgan JA
    J Card Surg; 2019 Feb; 34(2):82-91. PubMed ID: 30710496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and outcomes after left ventricular assist device implantation: insights from the EUROMACS Registry.
    Angleitner P; Kaider A; De By TMMH; Dimitrov K; Schlöglhofer T; Tops LF; Fiane AE; Rábago G; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35894678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices.
    Galand V; Flécher E; Lelong B; Chabanne C; Charton M; Goéminne C; Vincentelli A; Porterie J; Delmas C; Nubret K; Pernot M; Kindo M; Hoang Minh T; Gaudard P; Rouvière P; Sénage T; Michel M; Boignard A; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Blanchart K; Babatasi G; Garnier F; Bielefeld M; Radu C; Hamon D; Bourguignon T; Genet T; Eschalier R; D'Ostrevy N; Bories MC; Varlet E; Vanhuyse F; Sadoul N; Leclercq C; Martins RP
    Am J Cardiol; 2020 Oct; 133():81-88. PubMed ID: 32861423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.